{
  "id" : "ss2018_corpus_sarcoma_75896",
  "algorithm" : "eod_public",
  "version" : "1.0",
  "name" : "SS2018: Corpus Sarcoma",
  "title" : "Summary Stage 2018: Corpus Sarcoma",
  "subtitle" : "Summary Stage 2018",
  "notes" : "**Corpus Sarcoma (including Adenosarcoma)**\n\nC540-C543, C548-C549, C559\nC540 Isthmus uteri\nC541 Endometrium\nC542 Myometrium\nC543 Fundus uteri\nC548 Overlapping lesion of corpus uteri\nC549 Corpus uteri\nC559 Uterus, NOS\n\n**Note 1:** The following sources were used in the development of this schema\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/)\n* Collaborative Stage Data Collection System, version 02.05:  https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 54 *Corpus Uteri-Sarcoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** Code 0 is not applicable for this schema.",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05.** American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging.** In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n(5) **Introduction to Female Reproductive Organs**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 631\n\n(6) Dizon, D.S., Olawaiye, A.B., Mutch, D.G., et al. **Corpus Uteri – Sarcoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 671-680",
  "last_modified" : "2018-03-12T16:39:56.627Z",
  "definition" : [ {
    "key" : "ss2018",
    "name" : "SS2018",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "0", "In situ, intraepithelial, noninvasive, preinvasive" ], [ "1", "Localized only (localized, NOS)\n- FIGO Stage IA\n  + Confined to endometrium or endocervix\n  + (Glandular, stromal, or both)\n- FIGO Stage IB\n  + Invasion of inner half of myometrium\n  + Tumor invades less than one-half of myometrium\n- FIGO Stage IC\n  + Invasion of outer half of myometrium\n  + Tumor invades one-half or more of myometrium\n- FIGO Stage I [NOS]\n  + Invasion of myometrium, NOS\n  + Invasive cancer confined to corpus uteri\n  + Tunica serosa of the visceral peritoneum (serosa covering the corpus)" ], [ "2", "Regional by direct extension only\n- FIGO Stage IIA\n  + Cervix uteri, NOS, but not beyond uterus\n  + Confined to endocervix (Glandular, stromal, or both)\n  + Extension or metastasis within true pelvis\n     * Adnexa, NOS\n     * Fallopian tube(s)\n     * Ligaments (broad, round, uterosacral)\n     * Ovary(ies)\n  + Invasion of myometrium WITH involvement of endocervix\n      + Parametrium\n  + Visceral peritoneum of pelvic organs excluding serosa of corpus uteri\n- FIGO Stage IIB\n  + Described clinically as \"frozen pelvis\", NOS \n  + Parietal serosa of pelvic cavity\n  + Pelvic wall(s)\n  + Ureter\n  + Vagina\n  + Vulva\n- FIGO Stage II [NOS]\n  + Bladder wall\n  + Bladder, NOS excluding mucosa\n  + Extension beyond uterus, within pelvis, NOS\n  + Peritoneal cytology positive for malignant cells\n  + Rectal wall\n  + Rectum, NOS excluding mucosa" ], [ "3", "Regional lymph node(s) involved only\n- Aortic (lateral [lumbar], Periaortic, NOS)\n- Iliac (external, internal [hypogastric], NOS)\n- Lateral (laterosacral)\n- Middle (promontorial) (Gerota’s node)\n- Obturator\n- Para-aortic\n- Paracervical\n- Parametrial\n- Pelvic, NOS\n- Presacral\n- Sacral\n- Uterosacral\n- Regional lymph node(s), NOS\n  + Lymph node(s), NOS" ], [ "4", "Regional by BOTH direct extension AND regional lymph node(s) involved\n- Codes (2) + (3)" ], [ "7", "Distant site(s)/lymph node(s) involved\n- Distant site(s) (including further contiguous extension)\n   + Cul de sac (rectouterine pouch)\n   + FIGO Stage IIIA, IIIB, III [NOS]\n      * Abdominal serosa (visceral or parietal peritoneum of abdomen)\n      * Infiltration of abdominal tissues\n      * Sigmoid colon\n      * Small intestine\n      * Other abdominal structures\n   + FIGO Stage IVA, IVB, IV [NOS]\n- Distant lymph node(s), NOS \n  + Deep inguinal, NOS\n     * Node of Cloquet or Rosenmuller (highest deep inguinal)\n  + Inguinal, NOS\n  + Superficial inguinal (femoral)\n- Distant metastasis, NOS\n  + Carcinomatosis\n  + Distant metastasis WITH or WITHOUT distant lymph node(s)" ], [ "9", "Unknown if extension or metastasis" ] ]
}